ArticleInternational journal of molecular sciences2025

The Anti-Parkinsonian A2A Receptor Antagonist Istradefylline (KW-6002) Attenuates Behavioral Abnormalities, Neuroinflammation, and Neurodegeneration in Cerebral Ischemia: An Adenosinergic Signaling Link Between Stroke and Parkinson's Disease.

Michael G Zaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.